Differentiating Human Pluripotent Stem Cells to Neural Crest Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating neural crest cells from human pluripotent cells are inefficient, require complex multistep procedures, and involve significant contamination with Pax6+ neural progenitor cells, limiting their utility in tissue engineering and regenerative medicine.
Innovation Solution
A single-step method involving the promotion of WNT signaling and blockade of Activin A/Smad pathway, along with inhibition of bone morphogenic protein (BMP), to differentiate human pluripotent cells into p75+ Hnk1+ Ap2+ neural crest-like cells without appreciable contamination with Pax6+ neural progenitor cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods for generating neural crest cells from human pluripotent cells are used, then neural crest cells can be generated, but the process is inefficient and requires complex multistep procedures
Solution Approach 1:
The patent segments the complex differentiation process into distinct signaling pathway control steps: WNT pathway activation, Activin A/Smad pathway blockade, and BMP inhibition. This segmentation allows each pathway to be independently controlled to achieve efficient neural crest cell generation in a simplified single-step protocol.
Solution Approach 2:
The patent utilizes parameter changes in signaling pathway activity to control cell fate. By adjusting the activation state of WNT signaling (promoting neural crest fate) and the inhibition state of Activin A/Smad and BMP pathways, the method achieves efficient differentiation without complex procedures.
2Manufacturing precision
If current methods for generating neural crest cells are used, then neural crest cells can be obtained, but significant contamination with Pax6+ neural progenitor cells occurs
Solution Approach 1:
The patent applies preliminary anti-action by pre-establishing signaling conditions that specifically inhibit Pax6+ neural progenitor cell formation while promoting neural crest cell differentiation. The combined blockade of Activin A/Smad and BMP pathways, along with WNT activation, creates a signaling environment that prevents contamination before it occurs.
Solution Approach 2:
The patent converts the potential harm of neural progenitor cell contamination into a benefit by using the same signaling pathways to actively promote neural crest cell differentiation. The WNT activation and pathway blockades that prevent contamination also drive the desired neural crest fate, turning a potential problem into a solution.
3Quantity of substance
If existing neural crest cell generation methods are used, then some neural crest cells can be produced, but the yield is relatively low
Solution Approach 1:
The patent achieves high yield by optimizing signaling pathway parameters: activating WNT signaling to promote neural crest fate and blocking Activin A/Smad and BMP pathways to prevent alternative fates. This parameter optimization results in efficient differentiation and high yields of p75+ Hnk1+ neural crest cells.
Data Source
AI summary
The present invention relates to the differentiation of human pluripotent cells, including human pluripotent stems cells to produce a self-renewing multipotent neural crest cell population in a single step method without the requirement of isolation of intermediate cells and without appreciable contamination (in certain preferred instances, virtually none) with Pax6+ neural progenitor cells in the population of p75+ Hnk1+ Ap2+ multipotent neural crest-like cells. The multipotent neural crest cell population obtained can be clonally amplified and maintained for >25 passages (>100 days) while retaining the capacity to differentiate into peripheral neurons, smooth muscle cells and mesenchymal precursor cells.